The Acharyya group demonstrated upregulation of IκB kinase/NF-κB (IKK/NF-κB) signaling in DMD and revealed that reduction of NF-κB or its upstream activator IKK improves the pathology and muscle function in mdx mice [87]. The gene discussed is NFKB1; the disease is Duchenne muscular dystrophy.